Safety and Efficacy of Lenvatinib in Subjects With HCC Progression After First Line Treatment With Checkpoint Inhibitors
Clinical trial NCT04428437 · TERMINATED
Trial details
- NCT number
- NCT04428437
- Sponsor
- Humanity & Health Medical Group Limited
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2022-07-02
- Primary completion
- 2023-09-30
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.